Communiqués DexCom, Inc. Mexican S.E.

Actions

DXCM *

US2521311074

Equipement, fournitures et distribution médicale

Cours en clôture Mexican S.E. 22/09/2026			Varia. 5j.	Varia. 1 janv.
1 536,29 ^MXN	+0,48 %		-.--%	+26,65 %

07/10	DexCom, Inc. : Evercore ISI revoit son opinion et passe à neutre	ZM
01/10	DexCom, Inc. : RBC Capital Markets favorable sur le dossier	ZM

Communiqués

07/10	Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time	BU
06/10	Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading	BU
28/09	Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	BU
14/09	Dexcom Promotes Jereme Sylvain to Chief Operating Officer	BU
10/09	Dexcom Appoints Glenn Boehnlein to Board of Directors	BU
01/09	Dexcom Announces Upcoming Conference Presentation	BU
30/07	DexCom: Q2 Earnings Snapshot	AQ
30/07	Dexcom Reports Second Quarter 2026 Financial Results	BU
22/07	Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program	BU
13/07	Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes	PU
13/07	LE DEXCOM G7 15 JOURS A OBTENU L’AUTORISATION DE SANTÉ CANADA : UNE DURÉE DE PORT PROLONGÉE ET UNE CONTINUITÉ AMÉLIORÉE POUR LES ADULTES CANADIENS VIVANT AVEC LE DIABÈTE	BU
09/07	Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time	BU
03/07	Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?	PR
23/06	Dexcom Further Advances Vision of Glucose Biosensing for All	BU
06/06	Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin	BU
04/06	Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026	BU
02/06	Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience	BU
26/05	Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users	BU
19/05	DexCom : Operations and Innovation Committee	PU
18/05	Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany	BU
14/05	Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day	BU
06/05	DexCom : Trade Association Report 2025	PU
05/05	Dexcom to Host Investor Day on May 14, 2026	BU
30/04	DexCom: Q1 Earnings Snapshot	AQ
30/04	Dexcom Reports First Quarter 2026 Financial Results	BU